JP5931035B2 - Customer advertising system for live streaming of lectures sponsored by pharmaceutical companies, mainly ethical drug wholesalers - Google Patents

Customer advertising system for live streaming of lectures sponsored by pharmaceutical companies, mainly ethical drug wholesalers Download PDF

Info

Publication number
JP5931035B2
JP5931035B2 JP2013212092A JP2013212092A JP5931035B2 JP 5931035 B2 JP5931035 B2 JP 5931035B2 JP 2013212092 A JP2013212092 A JP 2013212092A JP 2013212092 A JP2013212092 A JP 2013212092A JP 5931035 B2 JP5931035 B2 JP 5931035B2
Authority
JP
Japan
Prior art keywords
pharmaceutical
user
symbol
terminal
wholesaler
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
JP2013212092A
Other languages
Japanese (ja)
Other versions
JP2015075945A (en
Inventor
康知 橋爪
康知 橋爪
Original Assignee
木村情報技術株式会社
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 木村情報技術株式会社 filed Critical 木村情報技術株式会社
Priority to JP2013212092A priority Critical patent/JP5931035B2/en
Publication of JP2015075945A publication Critical patent/JP2015075945A/en
Application granted granted Critical
Publication of JP5931035B2 publication Critical patent/JP5931035B2/en
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Landscapes

  • Management, Administration, Business Operations System, And Electronic Commerce (AREA)

Description

本発明は、製薬会社の端末と、医薬品に関する講演の配信者の端末と、医療用医薬品卸売業者の端末と、前記医薬品を使用する使用者の端末とを電気通信回線網で接続し、前記医療用医薬品卸売業者が前記医薬品の使用者に対して前記医薬品に関する講演を告知する広告を行うとともに前記医薬品に関する講演の配信者が前記医療用医薬品卸売業者に広告費用を支払う医療用医薬品卸売業者を主体とした製薬会社主催の講演会ライブ配信に関する集客広告システムに関するものである。
The present invention connects a terminal of a pharmaceutical company, a terminal of a distributor of a lecture on medicines, a terminal of a medical drug wholesaler, and a terminal of a user who uses the medicine through a telecommunication network, and The pharmaceutical wholesaler conducts advertisements to inform the users of the pharmaceuticals of the lectures on the pharmaceuticals, and the distributor of the lectures on the pharmaceuticals mainly pays the advertising costs to the ethical pharmaceutical wholesalers. This is related to the advertising system for attracting customers for live streaming of lectures organized by pharmaceutical companies.

近年では、インターネットに代表される電気通信回線網の普及によって、医薬品の使用者が医薬品に関する講演を電気通信回線網を介して視聴することができる(たとえば、特許文献1参照。)。   In recent years, with the widespread use of telecommunications network represented by the Internet, pharmaceutical users can view lectures on pharmaceutical products through the telecommunications network (for example, see Patent Document 1).

従来においては、製薬会社自らが、配信者に依頼して医薬品に関する講演を作成するとともに、医薬品の使用者に対して講演の告知をする広告を行っている。   Conventionally, pharmaceutical companies themselves make a lecture about pharmaceuticals by requesting a distributor, and also make advertisements for notifying users of pharmaceuticals.

一方、医薬品については、製薬会社自らが使用者に直接的に販売することが禁止されており、製薬会社とは別の複数の医療用医薬品卸売業者が使用者に販売している。   On the other hand, pharmaceutical companies themselves are prohibited from selling directly to users, and multiple ethical drug wholesalers different from pharmaceutical companies sell to users.

特開2007−60032号公報JP 2007-60032 A

製薬会社に比べて医薬品の使用者が圧倒的に多数存在しているために、全ての使用者に対して製薬会社自らが広告を行うことは困難である。   Since there are an overwhelming number of users of pharmaceuticals compared to pharmaceutical companies, it is difficult for pharmaceutical companies themselves to advertise to all users.

また、医薬品等の医薬品では製薬会社自らが使用者に直接販売することが禁止されている場合もあり、使用者との直接的な接点の少ない製薬会社が広告を行っても望ましい広告効果が得られないおそれもある。   In addition, pharmaceuticals such as pharmaceuticals may be prohibited from being sold directly to users by the pharmaceutical company itself, and even if a pharmaceutical company with few direct contacts with the user advertises, a desirable advertising effect can be obtained. There is also a risk that it will not be possible.

そこで、請求項1に係る本発明では、製薬会社の端末と、医薬品に関する講演の配信者の端末と、医療用医薬品卸売業者の端末と、前記医薬品を使用する使用者の端末とを電気通信回線網で接続し、前記医療用医薬品卸売業者が前記医薬品の使用者に対して前記医薬品に関する講演を告知する広告を行うとともに前記医薬品に関する講演の配信者が前記医療用医薬品卸売業者に広告費用を支払う医療用医薬品卸売業者を主体とした製薬会社主催の講演会ライブ配信に関する集客広告システムであって、前記医薬品に関する講演の配信者の端末は、前記医療用医薬品卸売業者が前記医薬品の使用者に配布した広告に記載された固有の広告記号と前記医薬品の使用者に固有の使用者記号と前記医療用医薬品卸売業者に固有の販売者記号とを前記医療用医薬品卸売業者の端末から前記電気通信回線網を介して受信するとともに、受信した広告記号の個数に応じて前記医療用医薬品卸売業者に支払う広告費用を算出し、前記医薬品の使用者が前記医療用医薬品卸売業者から配布された広告に記載された広告記号と前記医薬品の使用者に固有の使用者記号とを前記医薬品の使用者の端末から前記電気通信回線網を介して受信し、前記医療用医薬品卸売業者の端末と前記医薬品の使用者の端末とからそれぞれ受信した広告記号と使用者記号とが一致する場合に、前記医薬品の使用者の端末に前記医薬品に関する講演を配信するとともに、受信した広告記号の個数に応じて前記医療用医薬品卸売業者に支払う広告費用を加算し、前記販売者記号と前記使用者記号とを前記製薬会社の端末に送信することにした。   Therefore, in the present invention according to claim 1, a terminal of a pharmaceutical company, a terminal of a distributor of lectures on medicines, a terminal of a wholesaler of ethical drugs, and a terminal of a user who uses the medicines are connected to an electric communication line. Connected to the network, the prescription drug wholesaler advertises the user of the drug to the lecture about the drug, and the distributor of the drug lecture pays the advertising cost to the prescription drug wholesaler. This is a system for attracting customers to live broadcasts of lectures hosted by pharmaceutical companies, mainly ethical drug wholesalers, and the distributors of the lectures on the drugs are distributed to users of the drugs by the drug wholesalers. The unique advertising symbol, the user symbol unique to the user of the pharmaceutical product, and the seller symbol unique to the wholesaler of the ethical pharmaceuticals. Receiving from the terminal of the pharmaceutical wholesaler via the telecommunications network, calculating the advertising cost to be paid to the medical pharmaceutical wholesaler according to the number of received advertising symbols, Receiving the advertisement symbol described in the advertisement distributed from the pharmaceutical wholesaler and the user symbol specific to the user of the drug from the terminal of the user of the drug via the telecommunication network, Deliver and receive a lecture on the pharmaceutical product to the terminal of the pharmaceutical user when the advertising symbol and the user symbol received from the terminal of the pharmaceutical pharmaceutical wholesaler and the terminal of the pharmaceutical user match, respectively The advertising cost to be paid to the ethical drug wholesaler is added according to the number of the advertising symbols, and the seller symbol and the user symbol are transmitted to the terminal of the pharmaceutical company. It was in the door.

また、請求項2に係る本発明では、前記請求項1に係る本発明において、前記医薬品に関する講演の配信者の端末は、複数の異なる医療用医薬品卸売業者がいる場合に、前記医療用医薬品卸売業者の端末と前記医薬品の使用者の端末とからそれぞれ受信した広告記号と使用者記号とが一致する広告記号に対応する販売者記号と、前記医療用医薬品卸売業者の端末と前記医薬品の使用者の端末とからそれぞれ受信した広告記号と使用者記号とが一致しない広告記号に対応する販売者記号とに分けて前記製薬会社の端末に送信することにした。   Also, in the present invention according to claim 2, in the present invention according to claim 1, the terminal of the distributor of the lecture on the pharmaceutical is the medical pharmaceutical wholesale when there are a plurality of different medical pharmaceutical wholesalers. A seller symbol corresponding to an advertising symbol that matches the advertising symbol and the user symbol respectively received from the vendor terminal and the pharmaceutical user terminal, the terminal for the prescription pharmaceutical wholesaler, and the user of the pharmaceutical agent It was decided that the advertising symbols received from each of the terminals and the seller symbols corresponding to the advertising symbols whose user symbols do not match are divided and transmitted to the terminal of the pharmaceutical company.

そして、本発明では、以下に記載する効果を奏する。   And in this invention, there exists an effect described below.

すなわち、本発明では、使用者に医薬品を直接的に販売する医療用医薬品卸売業者が医薬品に関する講演の広告を使用者に対して行うことで、広告効果の向上が得られる。   That is, according to the present invention, an advertising effect can be improved by a medical drug wholesaler who directly sells a drug to the user performing an advertisement for a lecture on the drug to the user.

これにより、製薬会社としては、自ら広告を行わなくても有効な広告効果が得られ、これまで広告に要していた労力や時間や費用を削減することができる。   Thereby, as a pharmaceutical company, an effective advertising effect can be obtained without advertising itself, and labor, time, and cost required for advertising can be reduced.

また、医薬品に関する講演の配信者としては、広告効果の向上に伴って講演を実際に視聴する使用者の数を増大させることができる。   Moreover, as a distributor of lectures on pharmaceuticals, the number of users who actually view the lectures can be increased with the improvement of the advertising effect.

また、医療用医薬品卸売業者としては、広告費用が得られるばかりでなく、広告活動とともに医薬品の販売活動を行うことができ、円滑な営業活動が促進される。   Moreover, as an ethical drug wholesaler, not only can advertising costs be obtained, but also sales activities of pharmaceuticals can be performed together with advertising activities, and smooth sales activities are promoted.

さらに、医薬品の使用者としては、講演の視聴によって医薬品に関する十分な知識を得ることができる。   Furthermore, as a user of a medicine, sufficient knowledge about the medicine can be obtained by viewing the lecture.

本発明の構成を模式的に示す説明図。BRIEF DESCRIPTION OF THE DRAWINGS Explanatory drawing which shows the structure of this invention typically. 本発明の運用を模式的に示す説明図。Explanatory drawing which shows operation | use of this invention typically. 本発明の運用を模式的に示す説明図。Explanatory drawing which shows operation | use of this invention typically. 本発明の運用を模式的に示す説明図。Explanatory drawing which shows operation | use of this invention typically. 本発明の運用を模式的に示す説明図。Explanatory drawing which shows operation | use of this invention typically. 本発明におけるデータの構成を模式的に示す説明図。Explanatory drawing which shows typically the structure of the data in this invention.

以下に、本発明に係る医療用医薬品卸売業者を主体とした製薬会社主催の講演会ライブ配信に関する集客広告システム(以下、「本システム」という。)の具体的な構成や運用について図面を参照しながら説明する。   In the following, referring to the drawings, a specific configuration and operation of a customer attracting advertisement system (hereinafter referred to as “this system”) related to live distribution of lectures sponsored by a pharmaceutical company led by a prescription pharmaceutical wholesaler according to the present invention. While explaining.

図1〜図5に示すように、本システム1では、製薬会社(医薬品の製造者)の端末(製造者端末2)と、医薬品に関する講演の配信者の端末(配信者端末3)と、医療用医薬品卸売業者(医薬品の販売者)の端末(販売者端末4a〜4c)と、医薬品を使用する使用者の端末(使用者端末5a〜5c)とが電気通信回線網6を介して接続されている。ここで、端末は、インターネットに代表される電気通信回線網6を利用して相互に通信する機能を有するコンピューター等の機器を指す。   As shown in FIG. 1 to FIG. 5, in the present system 1, a terminal (manufacturer terminal 2) of a pharmaceutical company (manufacturer of pharmaceuticals), a terminal (distributor terminal 3) of a distributor of lectures on pharmaceuticals, The terminal (seller terminal 4a-4c) of the pharmaceutical wholesaler for medical use (pharmaceutical seller) and the terminal (user terminal 5a-5c) of the user who uses the drug are connected via the telecommunication network 6. ing. Here, the terminal refers to a device such as a computer having a function of communicating with each other using a telecommunication network 6 represented by the Internet.

そして、本システム1では、医療用医薬品卸売業者が医薬品の使用者に対して製薬会社が主催する医薬品に関する講演を告知する広告を行い、医薬品に関する講演の配信者が医療用医薬品卸売業者に対して広告費用を支払うシステムとなっている。   In this system 1, an ethical drug wholesaler advertises a drug user-sponsored drug lecture to a drug user, and the drug lecturer distributes the drug drug distributor to the drug wholesaler. It is a system that pays advertising costs.

まず、本システム1では、製薬会社からの委託を受けて配信者が医薬品に関する講演を作成する。この講演は、医薬品の効能や使用方法等の医薬品に関する講演内容を撮影・録音して作成される。講演は、講演データが電気通信回線網6を介して配信者端末3から使用者端末5a〜5cに配信されることで使用者に視聴される。   First, in the present system 1, a distributor creates a lecture about a medicine under the commission of a pharmaceutical company. This lecture will be created by recording and recording the contents of the lecture on drugs such as the efficacy and usage of the drugs. The lecture is viewed by the user by delivering the lecture data from the distributor terminal 3 to the user terminals 5 a to 5 c via the telecommunication network 6.

また、本システム1では、製薬会社から配信者が講演を告知する広告の作成及び配布を委託される。この広告には、講演の内容等が記載され、更に1枚毎に固有の識別記号(広告記号)が記載されている。広告は、配信者から医療用医薬品卸売業者に渡され、医療用医薬品卸売業者が医薬品の使用者に対して配布する。使用者は、医療用医薬品卸売業者から配布された広告を見て、使用者端末5a〜5cを用いて配信者端末3にアクセスすることで、講演を視聴する。   In the present system 1, a pharmaceutical company is entrusted with the creation and distribution of an advertisement for a distributor to announce a lecture. In this advertisement, the contents of the lecture and the like are described, and further, a unique identification symbol (advertisement symbol) is described for each sheet. The advertisement is delivered from the distributor to the ethical drug wholesaler, and the ethical drug wholesaler distributes it to the user of the drug. The user watches the lecture by viewing the advertisement distributed from the prescription pharmaceutical wholesaler and accessing the distributor terminal 3 using the user terminals 5a to 5c.

この本システム1において、医療用医薬品卸売業者は、広告を医薬品の使用者に配布した場合に医療用医薬品卸売業者に固有の識別記号(販売者記号)と、広告を配布した使用者に固有の識別記号(使用者記号)と、その使用者に実際に配布した広告に記載されている広告記号とを、販売者端末4a〜4cから配信者端末3に送信する。なお、販売者記号や使用者記号は、配信者から予め付与されたものである。   In this system 1, an ethical drug wholesaler, when distributing an advertisement to a user of a drug, has an identification code (seller symbol) unique to the ethical drug wholesaler and a user specific to the user who distributed the advertisement. The identification symbol (user symbol) and the advertisement symbol described in the advertisement actually distributed to the user are transmitted from the seller terminals 4a to 4c to the distributor terminal 3. The seller symbol and the user symbol are given in advance by the distributor.

これにより、本システム1では、配信者端末3は、医療用医薬品卸売業者が医薬品の使用者に配布した広告に記載された固有の広告記号と、医薬品の使用者に固有の使用者記号と、医療用医薬品卸売業者に固有の販売者記号とを医療用医薬品卸売業者端末4a〜4cから電気通信回線網6を介して受信する(図2参照。)。   Thereby, in the present system 1, the distributor terminal 3 has the unique advertising symbol described in the advertisement distributed to the user of the pharmaceutical by the ethical pharmaceutical wholesaler, the user symbol specific to the pharmaceutical user, The seller symbol unique to the ethical drug wholesaler is received from the ethical drug wholesaler terminals 4a to 4c via the telecommunication network 6 (see FIG. 2).

たとえば、販売者記号4Aの医療用医薬品卸売業者が、広告記号001の広告を使用者記号5Aの使用者に配布した場合、配信者端末3は、販売者端末4aから販売者記号4A、広告記号001、使用者記号5Aを含むデータを受信する。配信者端末3は、販売者端末4a〜4cから受信した販売者記号、広告記号、使用者記号に基づいて、配布された広告とその広告を配布した医療用医薬品卸売業者と広告が配布された使用者とを関連付ける一連の集計データとして広告配布データを作成する(図6参照。)。   For example, when the ethical drug wholesaler with the seller symbol 4A distributes the advertisement with the advertisement symbol 001 to the user with the user symbol 5A, the distributor terminal 3 receives the seller symbol 4A, the advertisement symbol from the seller terminal 4a. 001, data including the user symbol 5A is received. The distributor terminal 3 is distributed with the distributed advertisement and the ethical pharmaceutical wholesaler that distributed the advertisement based on the seller symbol, the advertisement symbol, and the user symbol received from the seller terminals 4a to 4c. Advertisement distribution data is created as a series of aggregated data for associating with users (see FIG. 6).

そして、本システム1では、配信者端末3は、販売者端末4a〜4cから受信した広告記号の個数に応じて医療用医薬品卸売業者に支払う広告費用を算出する。その場合に、配信者端末3は、広告配布データを用いて表計算処理することで、医療用医薬品卸売業者毎の広告配布数を求めた広告配布集計データを作成する。なお、広告費用としては、医療用医薬品卸売業者毎に予め設定された広告の配布に対する単価を医療用医薬品卸売業者毎の広告配布数に乗じることで算出できる。   In the present system 1, the distributor terminal 3 calculates the advertising cost to be paid to the ethical pharmaceutical wholesaler according to the number of advertising symbols received from the seller terminals 4a to 4c. In that case, the distributor terminal 3 performs spreadsheet processing using the advertisement distribution data, thereby creating advertisement distribution total data for which the number of advertisement distributions for each ethical pharmaceutical wholesaler is obtained. The advertising cost can be calculated by multiplying the unit price for advertisement distribution preset for each ethical drug wholesaler by the number of advertisement distributions for each ethical drug wholesaler.

広告を配布された使用者は、使用者端末5a〜5cを用いて配信者端末3にアクセスすることで講演を視聴する。   The user distributed with the advertisement views the lecture by accessing the distributor terminal 3 using the user terminals 5a to 5c.

その際に、使用者は、使用者端末5a〜5cから使用者記号だけでなく、広告記号を配信者端末3に送信するよう要求される。この要求に応じて、使用者は、使用者記号と広告記号とを、使用者端末5a〜5cから配信者端末3に送信する。   At that time, the user is requested to transmit not only the user symbol but also the advertisement symbol to the distributor terminal 3 from the user terminals 5a to 5c. In response to this request, the user transmits the user symbol and the advertisement symbol from the user terminals 5a to 5c to the distributor terminal 3.

これにより、本システム1では、医薬品の使用者が医療用医薬品卸売業者から配布された広告に記載された広告記号と、医薬品の使用者に固有の使用者記号とを医薬品の使用者端末5a〜5cから電気通信回線網6を介して受信する(図3参照。)。   Thereby, in this system 1, the user symbol 5a to the drug user terminal 5a to the advertisement symbol described in the advertisement distributed by the pharmaceutical user from the ethical drug wholesaler and the user symbol unique to the drug user are displayed. 5c is received via the telecommunication network 6 (see FIG. 3).

たとえば、使用者記号5Bの使用者が、販売者記号4Cの医療用医薬品卸売業者から配布された広告記号022の広告を見て講演を視聴した場合、配信者端末3は、使用者端末5bから使用者記号5B、広告記号022を含むデータを受信する。配信者端末3は、使用者端末5a〜5cから受信した使用者記号、広告記号に基づいて、講演を視聴した使用者とその契機となった広告とを関連付ける一連の集計データとして講演視聴データを作成する(図6参照。)。   For example, when the user of the user symbol 5B watches the lecture by watching the advertisement of the advertisement symbol 022 distributed from the ethical drug wholesaler of the seller symbol 4C, the distributor terminal 3 is connected to the user terminal 5b. Data including the user symbol 5B and the advertisement symbol 022 is received. Based on the user symbols and advertisement symbols received from the user terminals 5a to 5c, the distributor terminal 3 provides the lecture viewing data as a series of aggregated data associating the user who viewed the lecture with the advertisement that triggered the lecture. Create (see FIG. 6).

また、配信者端末3は、販売者端末4a〜4cから受信した広告記号と使用者記号と、使用者端末5a〜5cから受信した広告記号と使用者記号とを比較し、販売者端末4a〜4cと使用者端末5a〜5cとからそれぞれ受信した広告記号と使用者記号とが一致する場合に限って、使用者端末5a〜5cに医薬品に関する講演を収録した講演データを配信する(図4参照。)。   Further, the distributor terminal 3 compares the advertisement symbol and user symbol received from the seller terminals 4a to 4c with the advertisement symbol received from the user terminals 5a to 5c and the user symbol, and the seller terminal 4a to Only when the advertisement symbol and the user symbol received from 4c and the user terminals 5a to 5c respectively match, the lecture data containing the lecture on the medicine is distributed to the user terminals 5a to 5c (see FIG. 4). .)

たとえば、使用者記号5Cの使用者から広告記号003に基づいて講演の視聴の要求がされた場合には、配信者端末3は、広告配布データから広告記号003の広告が使用者記号5Cの使用者に販売者記号4Aの医療用医薬品卸売業者から配布されたことを検出し、使用者記号5Cの使用者から受信した広告記号003及び使用者記号5Cが販売者記号4Aの医療用医薬品卸売業者から受信した広告記号003及び使用者記号5Cと一致すると判断し、使用者記号5Cの使用者に対して講演の視聴を許可する。配信者端末3は、使用者端末5a〜5cから受信した使用者記号、広告記号に基づいて、その広告(使用者が講演を視聴する契機として有効に機能した広告)を配布した医療用医薬品卸売業者とを関連付ける一連の集計データとして有効広告配布データを作成する(図6参照。)。   For example, when the user of the user symbol 5C requests to view the lecture based on the advertisement symbol 003, the distributor terminal 3 uses the advertisement of the advertisement symbol 003 from the advertisement distribution data. The advertising symbol 003 and the user symbol 5C received from the user of the user symbol 5C are detected from the distributor of the pharmaceutical symbol wholesaler of the seller symbol 4A. It is determined that it matches the advertisement symbol 003 and the user symbol 5C received from the user, and the user of the user symbol 5C is permitted to view the lecture. The distributor terminal 3 distributes the advertisement (the advertisement that functioned effectively as an opportunity for the user to view the lecture) based on the user symbol and the advertisement symbol received from the user terminals 5a to 5c. Valid advertisement distribution data is created as a series of aggregated data for associating with a merchant (see FIG. 6).

そして、本システム1では、配信者端末3は、使用者端末5a〜5cから受信した広告記号の個数に応じて医療用医薬品卸売業者に追加して支払う広告費用を算出する。その場合に、配信者端末3は、有効広告配布データを用いて表計算処理することで、医療用医薬品卸売業者毎の有効広告数を求めた有効広告集計データを作成する。なお、加算する広告費用としては、医療用医薬品卸売業者毎に予め設定された有効な広告の配布に対する単価を医療用医薬品卸売業者毎の有効広告数に乗じることで算出できる。   In the present system 1, the distributor terminal 3 calculates an advertising cost to be additionally paid to the ethical pharmaceutical wholesaler according to the number of advertising symbols received from the user terminals 5a to 5c. In that case, the distributor terminal 3 performs spreadsheet processing using the effective advertisement distribution data, thereby creating effective advertisement total data for which the number of effective advertisements for each ethical pharmaceutical wholesaler is obtained. The advertisement cost to be added can be calculated by multiplying the number of effective advertisements for each ethical drug wholesaler by the unit price for the distribution of valid advertisements preset for each ethical drug wholesaler.

配信者は、医療用医薬品卸売業者に対して広告費用として、広告配布数に応じた費用に有効広告数に応じた費用を加算した費用を支払う。   The distributor pays a cost obtained by adding a cost according to the number of effective advertisements to a cost according to the number of advertisement distributions as an advertising cost to the ethical drug wholesaler.

また、配信者は、製薬会社に対して医療用医薬品卸売業者毎の広告実績を報告する。その場合には、配信者端末3が製造者端末2に販売者記号と使用者記号とを送信する(図5参照。)。その際に、配信者端末3は、販売者端末4a〜4cと使用者端末5a〜5cとからそれぞれ受信した広告記号と使用者記号とが一致する広告記号に対応する販売者記号と、販売者端末4a〜4cと使用者端末5a〜5cとからそれぞれ受信した広告記号と使用者記号とが一致しない広告記号に対応する販売者記号とに分けて製造者端末2に送信する。   In addition, the distributor reports the advertisement performance of each ethical drug wholesaler to the pharmaceutical company. In that case, the distributor terminal 3 transmits the seller symbol and the user symbol to the manufacturer terminal 2 (see FIG. 5). At that time, the distributor terminal 3 includes the seller symbol corresponding to the advertisement symbol that matches the advertisement symbol and the user symbol respectively received from the seller terminals 4a to 4c and the user terminals 5a to 5c, and the seller. The advertisement symbol received from each of the terminals 4a to 4c and the user terminals 5a to 5c and the seller symbol corresponding to the advertisement symbol that does not match the user symbol are transmitted to the manufacturer terminal 2.

たとえば、使用者記号5Bの使用者に対して販売者記号4A、4B、4Cの医療用医薬品卸売業者から広告が配布されたが、使用者が販売者記号4Cの医療用医薬品卸売業者から配布された広告に基づいて講演を視聴した場合、広告を配布したが講演の視聴に繋がらなかった広告を配布した医療用医薬品卸売業者の販売者記号4A、4Bと、講演の視聴に繋がった広告を配布した医療用医薬品卸売業者の販売者記号4Cとが区別できるようにして製薬会社に報告する。その際に、配信者端末3は、広告配布データと有効広告配布データとを用いて表計算処理することで、広告が配布された使用者と講演の視聴に繋がる広告を配布した医療用医薬品卸売業者と講演の視聴に繋がらなかった広告を配布した医療用医薬品卸売業者とを関連付ける一連の集計データとして報告データを作成し、その報告データを製造者端末2に送信する。   For example, an advertisement is distributed to a user of the user symbol 5B from a medical drug wholesaler of the seller symbol 4A, 4B, 4C, but a user is distributed from a medical drug wholesaler of the seller symbol 4C. When viewing the lecture based on the advertisement, the distributor sign 4A, 4B of the ethical pharmaceutical wholesaler that distributed the advertisement but did not lead to the viewing of the lecture, and the advertisement that led to the viewing of the lecture The information is reported to the pharmaceutical company in such a manner that it can be distinguished from the seller symbol 4C of the ethical drug wholesaler. At that time, the distributor terminal 3 performs spreadsheet processing using the advertisement distribution data and the effective advertisement distribution data, thereby distributing the medical drug wholesale that distributes the advertisement distributed to the user to whom the advertisement is distributed and the viewing of the lecture. Report data is created as a series of aggregated data for associating the vendor with the prescription pharmaceutical wholesaler who has distributed the advertisement that did not lead to the viewing of the lecture, and the report data is transmitted to the manufacturer terminal 2.

以上に説明したように、上記本システム1では、製薬会社が自ら講演を告知する広告を行うのではなく、医療用医薬品卸売業者が医薬品の使用者に対して医薬品に関する講演を告知する広告を行い、医薬品に関する講演の配信者が医療用医薬品卸売業者に対して広告費用を支払うシステムとなっている。   As described above, in the system 1, the pharmaceutical company does not advertise itself to give a lecture, but the ethical drug wholesaler advertises a drug-related lecture to the drug user. This is a system in which distributors of lectures on pharmaceuticals pay advertising costs to ethical drug wholesalers.

そのため、上記本システム1では、医薬品の使用者に医薬品を直接的に販売する医療用医薬品卸売業者が医薬品に関する講演の広告を使用者に対して行うことで、広告効果の向上が得られる。   For this reason, in the system 1 described above, an advertisement effect can be improved by an ethical drug wholesaler that directly sells a drug to a user of the drug, by advertising a lecture about the drug to the user.

そして、製薬会社としては、自ら広告を行わなくても有効な広告効果が得られ、これまで広告に要していた労力や時間や費用を削減することができる。   And as a pharmaceutical company, an effective advertising effect can be obtained without advertising itself, and labor, time, and cost required for advertising can be reduced.

また、医薬品に関する講演の配信者としては、広告効果の向上に伴って講演を実際に視聴する使用者の数を増大させることができる。   Moreover, as a distributor of lectures on pharmaceuticals, the number of users who actually view the lectures can be increased with the improvement of the advertising effect.

また、医療用医薬品卸売業者としては、広告費用が得られるばかりでなく、広告活動とともに医薬品の販売活動を行うことができ、円滑な営業活動が促進される。   Moreover, as an ethical drug wholesaler, not only can advertising costs be obtained, but also sales activities of pharmaceuticals can be performed together with advertising activities, and smooth sales activities are promoted.

さらに、医薬品の使用者としては、講演の視聴によって医薬品に関する十分な知識を得ることができる。   Furthermore, as a user of a medicine, sufficient knowledge about the medicine can be obtained by viewing the lecture.

なお、本発明は、医薬品以外の商品を製造や販売する製造者や販売者についても適用することができる。   In addition, this invention is applicable also to the manufacturer and seller who manufacture and sell goods other than a pharmaceutical.

1 本システム
2 製造者端末
3 配信者端末
4a〜4c 販売者端末
5a〜5c 使用者端末
6 電気通信回線網
DESCRIPTION OF SYMBOLS 1 This system 2 Manufacturer terminal 3 Distributor terminal 4a-4c Seller terminal 5a-5c User terminal 6 Telecommunication network

Claims (2)

製薬会社の端末と、医薬品に関する講演の配信者の端末と、医療用医薬品卸売業者の端末と、前記医薬品を使用する使用者の端末とを電気通信回線網で接続し、前記医療用医薬品卸売業者が前記医薬品の使用者に対して前記医薬品に関する講演を告知する広告を行うとともに前記医薬品に関する講演の配信者が前記医療用医薬品卸売業者に広告費用を支払う医療用医薬品卸売業者を主体とした製薬会社主催の講演会ライブ配信に関する集客広告システムであって、
前記医薬品に関する講演の配信者の端末は、
前記医療用医薬品卸売業者が前記医薬品の使用者に配布した広告に記載された固有の広告記号と前記医薬品の使用者に固有の使用者記号と前記医療用医薬品卸売業者に固有の販売者記号とを前記医療用医薬品卸売業者の端末から前記電気通信回線網を介して受信するとともに、受信した広告記号の個数に応じて前記医療用医薬品卸売業者に支払う広告費用を算出し、
前記医薬品の使用者が前記医療用医薬品卸売業者から配布された広告に記載された広告記号と前記医薬品の使用者に固有の使用者記号とを前記医薬品の使用者の端末から前記電気通信回線網を介して受信し、
前記医療用医薬品卸売業者の端末と前記医薬品の使用者の端末とからそれぞれ受信した広告記号と使用者記号とが一致する場合に、前記医薬品の使用者の端末に前記医薬品に関する講演を配信するとともに、受信した広告記号の個数に応じて前記医療用医薬品卸売業者に支払う広告費用を加算し、
前記販売者記号と前記使用者記号とを前記製薬会社の端末に送信することを特徴とする医療用医薬品卸売業者を主体とした製薬会社主催の講演会ライブ配信に関する集客広告システム。
A terminal of a pharmaceutical company, a terminal of a distributor of lectures on medicines, a terminal of a prescription pharmaceutical wholesaler, and a terminal of a user who uses the medicine are connected by a telecommunication network, and the prescription pharmaceutical wholesaler A pharmaceutical company mainly composed of a prescription pharmaceutical wholesaler who makes an advertisement to notify the user of the pharmaceutical product of the lecture about the pharmaceutical product and the distributor of the lecture about the pharmaceutical product pays the advertising cost to the prescription pharmaceutical wholesaler It is an advertising system for attracting customers about live streaming of sponsored lectures,
The terminal of the distributor of the lecture on the drug is
A unique advertising symbol written in an advertisement distributed to a user of the pharmaceutical by the prescription pharmaceutical wholesaler, a user symbol specific to the user of the pharmaceutical product, and a seller symbol specific to the wholesaler of the prescription pharmaceutical Is received from the terminal of the prescription pharmaceutical wholesaler via the telecommunication network, and the advertising cost to be paid to the prescription pharmaceutical wholesaler is calculated according to the number of received advertising symbols,
The telecommunications network includes an advertisement symbol written in an advertisement distributed by the ethical drug wholesaler and a user symbol unique to the pharmacy user from the terminal of the pharmacy user. Received through
When the advertising symbol received from the terminal of the ethical pharmaceutical wholesaler and the terminal of the user of the pharmaceutical match the user symbol, the lecture on the pharmaceutical is delivered to the terminal of the user of the pharmaceutical , Add the advertising costs to be paid to the ethical drug wholesaler according to the number of advertising symbols received,
A customer advertisement system related to live distribution of lectures sponsored by a pharmaceutical company, mainly a prescription pharmaceutical wholesaler, wherein the seller symbol and the user symbol are transmitted to a terminal of the pharmaceutical company.
前記医薬品に関する講演の配信者の端末は、複数の異なる医療用医薬品卸売業者がいる場合に、前記医療用医薬品卸売業者の端末と前記医薬品の使用者の端末とからそれぞれ受信した広告記号と使用者記号とが一致する広告記号に対応する販売者記号と、前記医療用医薬品卸売業者の端末と前記医薬品の使用者の端末とからそれぞれ受信した広告記号と使用者記号とが一致しない広告記号に対応する販売者記号とに分けて前記製薬会社の端末に送信することを特徴とする請求項1に記載の医療用医薬品卸売業者を主体とした製薬会社主催の講演会ライブ配信に関する集客広告システム。
When there are a plurality of different ethical drug wholesalers, the terminal of the distributor of the lecture on the drug is the advertisement symbol and the user respectively received from the terminal of the drug wholesaler and the user terminal of the drug Corresponds to the seller symbol corresponding to the advertising symbol that matches the symbol, and the advertising symbol that does not match the user symbol and the advertising symbol received from the terminal of the ethical pharmaceutical wholesaler and the terminal of the pharmaceutical user, respectively. The customer advertisement system for live delivery of lectures sponsored by a pharmaceutical company based on a prescription pharmaceutical wholesaler according to claim 1, wherein the information is transmitted to the terminal of the pharmaceutical company separately.
JP2013212092A 2013-10-09 2013-10-09 Customer advertising system for live streaming of lectures sponsored by pharmaceutical companies, mainly ethical drug wholesalers Expired - Fee Related JP5931035B2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2013212092A JP5931035B2 (en) 2013-10-09 2013-10-09 Customer advertising system for live streaming of lectures sponsored by pharmaceutical companies, mainly ethical drug wholesalers

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2013212092A JP5931035B2 (en) 2013-10-09 2013-10-09 Customer advertising system for live streaming of lectures sponsored by pharmaceutical companies, mainly ethical drug wholesalers

Publications (2)

Publication Number Publication Date
JP2015075945A JP2015075945A (en) 2015-04-20
JP5931035B2 true JP5931035B2 (en) 2016-06-08

Family

ID=53000746

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2013212092A Expired - Fee Related JP5931035B2 (en) 2013-10-09 2013-10-09 Customer advertising system for live streaming of lectures sponsored by pharmaceutical companies, mainly ethical drug wholesalers

Country Status (1)

Country Link
JP (1) JP5931035B2 (en)

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2003263597A (en) * 2002-03-11 2003-09-19 So-Net M3 Kk Marketing support device and marketing support method
JP2005189977A (en) * 2003-12-24 2005-07-14 Shop System Study Society Advertising medium utilizing method and system
US20070265912A1 (en) * 2006-05-09 2007-11-15 Goss International Americas, Inc. System and method for tracking advertising effectiveness using redeemable incentives
JP2009123073A (en) * 2007-11-16 2009-06-04 Japan System Development Co Ltd Advertisement management system and advertisement management method

Also Published As

Publication number Publication date
JP2015075945A (en) 2015-04-20

Similar Documents

Publication Publication Date Title
US10748168B1 (en) Systems and methods for tracking referrals among a plurality of members of a social network
US20230283860A1 (en) Value-based tv advertising audience exchange
KR102113128B1 (en) Selling platform server for counting goods sales quantaties per seller on influencer marketing platform and operating method of selling platform server
US20130060644A1 (en) Interaction-based pricing of electronic ads
JP2015179469A (en) Distribution device, distribution method, and distribution program
KR101114643B1 (en) Advertisement system using smart phone
US20130173400A1 (en) Audience-driven real-time advertising system
US20170249673A1 (en) Out-of-home and/or home targeted interactive content, infomercial and advertising
JP2014146274A5 (en)
US20160189206A1 (en) Monitoring method and device for display number of pictures
JP5931035B2 (en) Customer advertising system for live streaming of lectures sponsored by pharmaceutical companies, mainly ethical drug wholesalers
JP2011180745A (en) Evaluation comment display system and evaluation comment display method
CN108109014B (en) Marketing system
JP2014127095A (en) Information distribution device and information distribution method
JP5843947B1 (en) Cookie information conversion apparatus, method and program
KR20150083953A (en) Apparatus and method for advertising using social network service, and the system thereof
KR101225230B1 (en) Payment service system for advertisement linked application of mobile device and method thereof
JP6905864B2 (en) Distribution device, distribution method and distribution program
KR20090000031A (en) Method and apparatus for providing internet advertisement base on user participation
US20120191540A1 (en) Automatic application of targeted advertising in datasets
US20110082725A1 (en) Application Software Video Channel
KR20150136627A (en) Apparatus and method for local area advertising
JP5755271B2 (en) Advertisement distribution device, advertisement distribution method, and advertisement distribution program
JP6433962B2 (en) Advertisement server and advertisement distribution system
JP5639143B2 (en) Ad delivery management system

Legal Events

Date Code Title Description
A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20150318

A977 Report on retrieval

Free format text: JAPANESE INTERMEDIATE CODE: A971007

Effective date: 20160119

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20160126

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20160323

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20160412

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20160426

R150 Certificate of patent or registration of utility model

Ref document number: 5931035

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

LAPS Cancellation because of no payment of annual fees